LAMP1 and lung carcinoma: Exosomal miR-23a derived from human lung cancer and leukemia cultured cell lines was shown to reduce NK in vitro cytotoxicity following co-incubation, likely due to reduced CD107a (LAMP-1) surface expression (60).